好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Spine and Spinal Cord Emergencies

Monday 04/23/12
09:30 AM - 11:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
J. D. Bartleson, MD, FAAN
Participants should be able to recognize and diagnose important causes of spinal cord dysfunction and its consequences. They should be able to diagnose and treat infectious and inflammatory conditions of the spinal cord, spondylotic compression of the spinal cord and cauda equina, and acute spine trauma.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Didactic

Program Evaluations

Event Timeline
09:30 AM - 10:05 AM Spine Emergencies Due to Inflammatory and Infectious Causes
Brian G. Weinshenker, MD, FAAN
09:30 AM - 11:30 AM Break
10:05 AM - 10:35 AM Spine Emergencies Due to Spondylosis
J. D. Bartleson, MD, FAAN
10:35 AM - 11:15 AM Spine Trauma
H. G. Deen, MD
11:15 AM - 11:30 AM Questions and Answers
Faculty Disclosures
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
H. G. Deen, MD No disclosure on file